High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
National Institutes of Health
Free. Verify your email, then we send one reminder only.
- Posted
- Dec 17, 2025
- Closes
- Mar 6, 2027 (in 220 days)
Classification and identifiers
- Solicitation number
- RFA-DA-25-024
- Assistance listing (CFDA)
- 93.279
Amount
Amount not published by the funder
Who can apply
Local government agencies, Public colleges and universities, and State government agencies can all apply here. Check the eligibility details below to see if your organization fits.
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
About this opportunity
The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelin...
Related opportunities
- High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)National Institutes of HealthCloses Mar 2027Up to $1.5M
- Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)National Institutes of HealthCloses Nov 2027
- Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)National Institutes of HealthCloses Dec 2027
- Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)National Institutes of HealthCloses Dec 2027
- Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)National Institutes of HealthCloses Nov 2027
- Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)National Institutes of HealthCloses May 2027